Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 22, 2017
Which patents cover Argatroban, and when can generic versions of Argatroban launch?
Argatroban is a drug marketed by Fresenius Kabi Usa, Hospira Inc, Mylan Institutional, Hikma Pharm Co Ltd, Par Sterile Products, Novartis Pharms Corp, Teva Pharms Usa, Sandoz, Eagle Pharms, and Gland Pharma Ltd. and is included in eleven NDAs. There are two patents protecting this drug and two Paragraph IV challenges.| Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Suppliers / Packagers: see list | 5 |
| Bulk Api Vendors: see list | 92 |
| Clinical Trials: see list | 19 |
| Patent Applications: see list | 3,748 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | ARGATROBAN at DailyMed |
| Drug Class | Anti-coagulant Direct Thrombin Inhibitor |
| Mechanism of Action | Thrombin Inhibitors |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 201811-001 | Mar 23, 2015 | AP | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Novartis Pharms Corp | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 020883-001 | Jun 30, 2000 | AP | RX | Yes | Yes | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Hikma Pharm Co Ltd | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 203049-002 | Sep 30, 2016 | RX | Yes | Yes | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Gland Pharma Ltd | ARGATROBAN IN SODIUM CHLORIDE | argatroban | INJECTABLE;IV (INFUSION) | 205570-001 | May 22, 2017 | AP | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Teva Pharms Usa | ARGATROBAN IN 0.9% SODIUM CHLORIDE | argatroban | INJECTABLE;IV (INFUSION) | 206769-001 | Dec 15, 2014 | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms Corp | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 020883-001 | Jun 30, 2000 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Novartis Pharms Corp | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 020883-001 | Jun 30, 2000 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Drugname | Dosage | Strength | RLD | Submissiondate |
|---|---|---|---|---|
| argatroban in sodium chloride | Injection | 1 mg/mL, 50 mL vials | Argatroban | 12/16/2011 |
| argatroban | Injection | 100 mg/mL, 2.5 mL vials | Argatroban | 9/24/2007 |
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,378 others who get our Drug Patent Expiration Alerts:
